Condition

Colonic Neoplasms

ClinicalTrials.gov condition label

Clinical trials15
Recruiting3
Common interventions25
Lead sponsors shown13

Clinical trials

15 shown
Laparoscopic Versus Open Surgery for Colon Cancer With Visceral ObesityNCT07314996 · 2026-01-18
RECRUITING
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including MesotheliomaNCT06885697 · 2025-07-08
RECRUITING
PRE-ISPY Phase I/II Oncology Platform ProgramNCT05868226 · 2023-02-15
RECRUITING
Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly PatientsNCT05068180 · 2021-10-05
UNKNOWN
A Study of ASN007 in Patients With Advanced Solid TumorsNCT03415126 · 2018-01-19
COMPLETED
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsNCT03037385 · 2017-03-17
COMPLETED
End-of-Life Care for African AmericansNCT02320123 · 2016-05-23
COMPLETED
PERCIST Criteria for Response Evaluation With Solid TumorsNCT02765620 · 2016-04-01
UNKNOWN
Cancer and Anesthesia: Survival After Radical Surgery - a Comparison Between Propofol or Sevoflurane AnesthesiaNCT01975064 · 2013-11-01
COMPLETED
Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR InhibitorsNCT01137162 · 2008-08-01
TERMINATED
Effect of High-Legume Diet on Colorectal Cancer RiskNCT00339469 · 2005-08-03
COMPLETED
MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.NCT00147550 · 2004-02-01
TERMINATED
A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by RituximabNCT00001805 · 1999-03-01
COMPLETED
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial CancersNCT00579163 · 1994-12-01
ACTIVE_NOT_RECRUITING
Women's Health Initiative (WHI)NCT00000611
COMPLETED

Common interventions

ALX148DRUG1ASN007 RDDRUG1ASN007: ascending dosesDRUG1calciumDRUG1cyclophosphamideDRUG1diet, fat-restrictedBEHAVIORAL1dietary supplementsBEHAVIORAL1drug&radiationOTHER1Educational DVDBEHAVIORAL1estrogen replacement therapyDRUG1estrogensDRUG1Fam-Trastuzumab Deruxtecan-NxkiDRUG1fludarabineDRUG1hormone replacement therapyDRUG1Laparoscopic surgeryPROCEDURE1LIFEDIETARY_SUPPLEMENT1low-dose neuroleptanalgesiaDRUG1mesothelin expression testingDEVICE1Open surgeryPROCEDURE1PD-0325901DRUG1PlaceboDRUG1pralsetinib (BLU-667)DRUG1progestinsDRUG1PropofolDRUG1RituximabDRUG1

Trial status mix

COMPLETED7
RECRUITING3
TERMINATED2
UNKNOWN2
ACTIVE_NOT_RECRUITING1

Phase mix

PHASE15
PHASE24
NA2
PHASE42
EARLY_PHASE11
PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.